Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020
Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused due to multidrug resistant microorganisms. The report analyzes the market for late stage candidates for treatment of nosocomial pneumonia, and also provides a detailed review of drugs in early stages of clinical trials. The report studies and estimates market for six late stage along with an elucidation of ten early stage candidates for nosocomial pneumonia treatment.
Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused due to multidrug resistant microorganisms. The report analyzes the market for late stage candidates for treatment of nosocomial pneumonia, and also provides a detailed review of drugs in early stages of clinical trials. The report studies and estimates market for six late stage along with an elucidation of ten early stage candidates for nosocomial pneumonia treatment.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Pipeline</strong> <strong>Analysis</strong> <strong>of</strong> <strong>Hospital</strong><br />
<strong>Acquired</strong> <strong>Pneumonia</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Chapter 3 <strong>Market</strong> overview<br />
3.1 Introduction<br />
3.1.1 Types <strong>of</strong> Nosocomial <strong>Pneumonia</strong><br />
3.1.1.1 Bacterial pneumonia<br />
3.1.1.2 Viral pneumonia<br />
3.1.2 Epidemiology <strong>of</strong> hospital acquired pneumonia<br />
3.1.3 Diagnosis <strong>of</strong> hospital acquired pneumonia<br />
3.1.4 Treatment <strong>of</strong> hospital acquired pneumonia<br />
3.2 <strong>Market</strong> Dynamics<br />
3.2.1 <strong>Market</strong> Drivers<br />
3.2.1.1 Rising drug resistance among infectious microorganisms increasing chances <strong>of</strong> hospital<br />
acquired infections<br />
3.2.1.2 Inefficient sterilization <strong>and</strong> unhygienic conditions in low <strong>and</strong> middle income countries<br />
increasing prevalence <strong>of</strong> hospital acquired infections<br />
3.2.1.2.1 Prevalence <strong>of</strong> hospital acquired infections in developed <strong>and</strong> developing countries<br />
3.2.2 <strong>Market</strong> Restraints<br />
3.2.2.1 Government scrutinizing hospital policies to curb hospital-acquired infections<br />
3.2.3 <strong>Market</strong> Opportunities<br />
3.2.3.1 Promising future for vaccines in the nosocomial pneumonia market<br />
pneumonia<br />
3.2.3.2 Potential for research in vaccine development for causative agents other than S.<br />
Transparency <strong>Market</strong> Research<br />
5
Change language